The European Investment Bank (EIB) will advise Antibiotice SA, one of Romania's largest pharmaceutical companies, on strengthening its corporate governance, with the aim of supporting its future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk management framework and business operations with international best practices in the pharmaceutical sector, the European Investment Bank announced.
The consultancy agreement follows a request from Antibiotice company aimed at strengthening its capacity to attract financing, support future investments, and consolidate long-term competitiveness in a rapidly evolving healthcare market. The EIB's support will also enhance transparency, operational oversight, and long-term sustainability across the company's activities.
Antibiotice, based in the municipality of Iasi, in northeastern Romania, offers over 200 products for human and veterinary use and has over 1,300 employees. Strengthening the company's competitiveness and development prospects through stronger governance will also contribute to economic development and job creation in Romania.
„”Ensuring that companies like Antibiotice are prepared for long-term investments means better healthcare, more jobs, and a stronger economy,„ stated Ioannis Tsakiris, Vice-President of the EIB. "This partnership reflects our commitment to helping key industries modernize, attract investment, and contribute to Romania's sustainable growth through InvestEU.".”
Antibiotice, a company majority-owned by the Romanian state, is a key domestic supplier of pharmaceutical products and a significant exporter of them to countries in Europe and around the world.
„This partnership with the EIB represents an important step in consolidating our long-term strategic development and continues the existing relationship” stated Ioan Nani, General Manager of Antibiotice.„The expertise and specialized support provided will help us better align with the highest international industry standards, create a solid foundation for new investments, and support long-term sustainable development. At the same time, they will contribute to expanding the company's international presence and maintaining our commitment to providing high-quality medicines to both Romanian citizens and international markets.”
BEI provides advisory support within the InvestEU Advisory Hub, which helps public and private entities across the European Union to develop sustainable and high-impact investment projects and strengthen their institutional capacity.
